CA2603899A1 - 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents - Google Patents

7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents Download PDF

Info

Publication number
CA2603899A1
CA2603899A1 CA002603899A CA2603899A CA2603899A1 CA 2603899 A1 CA2603899 A1 CA 2603899A1 CA 002603899 A CA002603899 A CA 002603899A CA 2603899 A CA2603899 A CA 2603899A CA 2603899 A1 CA2603899 A1 CA 2603899A1
Authority
CA
Canada
Prior art keywords
fluoro
compound
indol
dihydro
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002603899A
Other languages
English (en)
French (fr)
Inventor
Mikhail Fedor Gordeev
Vara Prasad Venkata Nagendra Josyula
Gary Wayne Luehr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2603899A1 publication Critical patent/CA2603899A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002603899A 2005-04-06 2006-03-27 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents Abandoned CA2603899A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US66871505P 2005-04-06 2005-04-06
US60/668,715 2005-04-06
US68403305P 2005-05-24 2005-05-24
US60/684,033 2005-05-24
PCT/IB2006/000954 WO2006106427A1 (en) 2005-04-06 2006-03-27 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents

Publications (1)

Publication Number Publication Date
CA2603899A1 true CA2603899A1 (en) 2006-10-12

Family

ID=36636389

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002603899A Abandoned CA2603899A1 (en) 2005-04-06 2006-03-27 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents

Country Status (21)

Country Link
US (1) US7435751B2 (cg-RX-API-DMAC10.html)
EP (1) EP1869030A1 (cg-RX-API-DMAC10.html)
JP (1) JP2008534672A (cg-RX-API-DMAC10.html)
KR (1) KR20070108938A (cg-RX-API-DMAC10.html)
AP (1) AP2007004172A0 (cg-RX-API-DMAC10.html)
AR (1) AR053839A1 (cg-RX-API-DMAC10.html)
AU (1) AU2006231919A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0610533A2 (cg-RX-API-DMAC10.html)
CA (1) CA2603899A1 (cg-RX-API-DMAC10.html)
CR (1) CR9417A (cg-RX-API-DMAC10.html)
DO (1) DOP2006000080A (cg-RX-API-DMAC10.html)
GT (1) GT200600133A (cg-RX-API-DMAC10.html)
IL (1) IL186119A0 (cg-RX-API-DMAC10.html)
MX (1) MX2007012386A (cg-RX-API-DMAC10.html)
NL (1) NL1031525C2 (cg-RX-API-DMAC10.html)
NO (1) NO20075505L (cg-RX-API-DMAC10.html)
PE (1) PE20061301A1 (cg-RX-API-DMAC10.html)
TN (1) TNSN07373A1 (cg-RX-API-DMAC10.html)
TW (1) TW200716101A (cg-RX-API-DMAC10.html)
UY (1) UY29452A1 (cg-RX-API-DMAC10.html)
WO (1) WO2006106427A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080262056A1 (en) * 2004-08-06 2008-10-23 Pfizer Inc Oxindole Oxazolidinones as Antibacterial Agents
KR100891485B1 (ko) 2007-10-29 2009-04-02 주식회사 만도 디스크 브레이크의 주차브레이크 장치
US20090124737A1 (en) * 2007-11-12 2009-05-14 Eastman Chemical Company Acrylic plastisol viscosity reducers

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2157934T3 (es) 1988-09-15 2001-09-01 Upjohn Co Fenil-5-beta-amidometiloxazolidin-2-onas sustituidas con nitrogeno en la posicion 3.
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
DE4425613A1 (de) 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE4425612A1 (de) 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
US6015429A (en) * 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
DE19649095A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue Heteroaryl-Oxazolidinone
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
CA2318969A1 (en) 1998-01-23 1999-07-29 Mikhail F. Gordeev Oxazolidinone combinatorial libraries, compositions and methods of preparation
DE69912264T2 (de) 1998-04-14 2004-07-22 Samsung Fine Chemicals Co., Ltd. Verfahren zur herstellung chiraler (s)-2,3-disubstituierter 1-propylamin-derivate
AU1379900A (en) 1998-11-17 2000-06-05 Bayer Aktiengesellschaft Novel substituted phenyloxazolidone derivatives
WO2000032599A1 (en) 1998-11-27 2000-06-08 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
EP1181288B1 (en) 1999-05-27 2003-07-30 PHARMACIA & UPJOHN COMPANY Bicyclic oxazolidinones as antibacterial agent
ATE321024T1 (de) 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
DE60212959T2 (de) 2001-04-07 2007-02-15 Astrazeneca Ab Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
ATE374463T1 (de) 2001-04-20 2007-10-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonen
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
US20080262056A1 (en) * 2004-08-06 2008-10-23 Pfizer Inc Oxindole Oxazolidinones as Antibacterial Agents

Also Published As

Publication number Publication date
MX2007012386A (es) 2007-11-07
US7435751B2 (en) 2008-10-14
WO2006106427A8 (en) 2007-12-06
CR9417A (es) 2007-12-04
NL1031525C2 (nl) 2007-01-30
KR20070108938A (ko) 2007-11-13
GT200600133A (es) 2006-11-29
WO2006106427A1 (en) 2006-10-12
TNSN07373A1 (fr) 2009-03-17
AR053839A1 (es) 2007-05-23
IL186119A0 (en) 2008-01-20
PE20061301A1 (es) 2007-02-09
NO20075505L (no) 2007-10-31
JP2008534672A (ja) 2008-08-28
BRPI0610533A2 (pt) 2010-06-29
NL1031525A1 (nl) 2006-10-09
US20060229349A1 (en) 2006-10-12
DOP2006000080A (es) 2006-12-15
AU2006231919A1 (en) 2006-10-12
TW200716101A (en) 2007-05-01
AP2007004172A0 (en) 2007-10-31
UY29452A1 (es) 2006-11-30
EP1869030A1 (en) 2007-12-26

Similar Documents

Publication Publication Date Title
WO2004002967A1 (en) Difluorothioacetamides of oxazolidinones as antibacterial agents
US7435751B2 (en) 7-Fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
ES2227166T3 (es) Agentes novedosos antibacterianos de benzosultamoxazolidinona.
EP1899331B1 (en) Homomorpholine oxazolidinones as antibacterial agents
US20080262056A1 (en) Oxindole Oxazolidinones as Antibacterial Agents
CA2614105A1 (en) Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents
US20060229348A1 (en) Oxindole oxazolidinone as antibacterial agent
CN101155806A (zh) 作为抗菌剂的羟吲哚唑烷酮
US20090149520A1 (en) Oxazolidinones containing oxindoles as antibacterial agents
CN101155805A (zh) 作为抗菌剂的7-氟-1,3-二氢-吲哚-2-酮唑烷酮
KR20070030952A (ko) 항바이러스제로서 옥신돌을 함유하는 옥사졸리딘온
JP2008521792A (ja) 抗菌薬としてのジアゼピンオキサゾリジノン
HK1104294A (en) Oxazolidinones containing oxindoles as antibacterial agents

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued